Pharmacogenetics testing is an increasingly important tool for clinical trial enrollment, interpretation of clinical data, and retrospective studies. Adverse events caused by genetic variants can halt a trial, mandate a black-box warning label, and result in an approved drug being pulled from the market. In some cases, drugs that fail to meet clinical efficacy endpoints are found to be effective for subsets of the population. To help mitigate these risks, we offer both comprehensive and tailored genotyping services for clinical trials and research studies. Our organization is a recognized leader in pharmacogenetics research and clinical testing, bringing deep expertise and an unparalleled testing platform to organizations running clinical trials.